Traded May 15 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded May 11, 2026 · Filed May 12, 2026
Encompass Health's Chief Operating Officer sold $71K of Encompass Health shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$71,310
Shares × reported transaction price
11 days after results of Apr 30, 2026, 86 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.4% | −0.1% | −1.3% |
| 30 days | −5.6% | −0.1% | −5.5% |
| 90 days | +16.6% | +3.8% | +12.8% |
Past results only. Not a forecast.
Traded May 15 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded May 15 · filed 3 days laterNot under a reported trading plan
The CFO of Encompass Health sold $2.96M of Encompass Health shares. The filing does not indicate a pre-arranged trading plan.
Traded May 15 · filed 3 days laterNot under a reported trading plan
The CFO of Encompass Health sold $107 of Encompass Health shares. The filing does not indicate a pre-arranged trading plan.